Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AIM ImmunoTech Inc.HEB · Entity 8131 | Sr. VP of Operations | June 21, 2019 | June 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AIM ImmunoTech Inc.
Report date June 21, 2019 · Filed June 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,672 |
Reported balance
After 2019-06-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-06-21 · Purchase · Acquired 5,211 · Balance 8,672 F1: Previous balance of the amount of securities owned was divided by 44 due to the 44/1 stock split that occurred on June 11, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Previous balance of the amount of securities owned was divided by 44 due to the 44/1 stock split that occurred on June 11, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2019 Filed Jun 24, 2019 21:01 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 5,211 | $4.03 | $21,000.33 |
DisclosureSEC source: 0001191434-19-000005 · primary_doc.xml · nonDerivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,672 F1 · balance_after: Previous balance of the amount of securities owned was divided by 44 due to the 44/1 stock split that occurred on June 11, 2019. Read SEC document |
| May 08, 2019 Filed Jun 17, 2019 20:11 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613377-19-000006 · primary_doc.xml · nonDerivative · entry 2 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares. Read SEC document |
| March 25, 2019 Filed Jun 17, 2019 20:11 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613377-19-000006 · primary_doc.xml · nonDerivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued. Read SEC document |
| February 28, 2019 Filed Mar 13, 2019 17:19 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSubr Rights(to buy) · Derivative | 10 | $1,000.00 Strike: $1,000.00 | $10,000.00 |
DisclosureSEC source: 0001583701-19-000003 · primary_doc.xml · derivative · entry 3 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Pref Stk/Warrants · Not disclosed shares Expires 2019-03-05 F1 · derivative.underlying: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F2 · derivative.underlying: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · derivative.underlying_shares: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| February 28, 2019 Filed Mar 13, 2019 17:19 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherWarrants | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000003 · primary_doc.xml · nonDerivative · entry 2 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F2 · security: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · shares: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · price: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| February 28, 2019 Filed Mar 13, 2019 17:19 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSeries B Convertible Preferred Stock | 10 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000003 · primary_doc.xml · nonDerivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10 F1 · security: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · shares: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · price: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 15:46 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 142,046 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001450324-19-000002 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,046 Underlying: Common Stock · 142,046 shares Expires 2029-01-28 F1 · security: This option is being issued to senior management for a voluntary 50% deferral in salary. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 14:42 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001613377-18-000034 · primary_doc.xml · nonDerivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,273 F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 16:38 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 1,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001613377-18-000030 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2028-11-14 F1 · security: This option has been awarded by the Board of Directors. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 16:08 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 94,697 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001613377-18-000023 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,697 Underlying: Common Stock · 94,697 shares Expires 2028-10-17 F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 14:06 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 32,259 | $0.31 | $10,000.29 |
DisclosureSEC source: 0001613377-18-000019 · primary_doc.xml · nonDerivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,773 Read SEC document |
| July 18, 2018 Filed Jul 19, 2018 15:57 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to Buy Common Stock · Derivative | 53,763 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001465652-18-000009 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,763 Underlying: Common Stock · 53,763 shares Expires 2028-07-18 F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:15 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 79,167 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001613377-18-000007 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,167 Underlying: Common Stock · 79,167 shares Expires 2028-05-16 F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| April 12, 2018 Filed Apr 19, 2018 17:17 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 75,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001465652-18-000002 · primary_doc.xml · derivative · entry 1 SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-04-12 F1 · security: This option is being awarded by the Board of Directors. Read SEC document |
| February 13, 2018 Filed Mar 1, 2018 17:38 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 111,486 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001613377-18-000002 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,486 Underlying: Common Stock · 111,486 shares Expires 2028-02-13 F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 17:07 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 7,339 | $0.26 Strike: $0.36 | $1,908.14 |
DisclosureSEC source: 0001613377-17-000040 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,339 Underlying: Common Stock · 7,339 shares Expires 2027-08-31 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:22 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 6,401 | $0.29 Strike: $0.41 | $1,856.29 |
DisclosureSEC source: 0001613377-17-000034 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,401 Underlying: Common Stock · 6,401 shares Expires 2027-08-15 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 16:18 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 6,236 | $0.30 Strike: $0.42 | $1,870.80 |
DisclosureSEC source: 0001613377-17-000028 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,236 Underlying: Common Stock · 6,236 shares Expires 2027-07-31 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| July 15, 2017 Filed Jul 17, 2017 20:11 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 5,438 | $0.34 Strike: $0.48 | $1,848.92 |
DisclosureSEC source: 0001613377-17-000022 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,438 Underlying: Common Stock · 5,438 shares Expires 2027-07-15 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:33 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 4,264 | $0.44 Strike: $0.49 | $1,876.16 |
DisclosureSEC source: 0001613377-17-000016 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · SR VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,264 Underlying: Common Stock · 4,264 shares Expires 2027-06-30 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 20:23 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 4,288 | $0.44 Strike: $0.54 | $1,886.72 |
DisclosureSEC source: 0001613377-17-000008 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,288 Underlying: Common Stock · 4,288 shares Expires 2027-06-25 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 15, 2017 Filed Jun 29, 2017 16:58 UTC Amendment | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 4,264 | $0.44 Strike: $0.49 | $1,876.16 |
DisclosureSEC source: 0001613377-17-000012 · primary_doc.xml · derivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,264 Underlying: Common Stock · 4,264 shares Expires 2027-06-15 F1 · security: Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017. F1 · price: Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017. Read SEC document |
| May 02, 2017 Filed May 3, 2017 15:33 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 15,873 | $0.63 | $9,999.99 |
DisclosureSEC source: 0001465652-17-000001 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,514 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 20:31 UTC Amendment | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 8,014 | $0.46 | $3,686.44 |
DisclosureSEC source: 0001613377-17-000004 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,641 F1 · balance_after: The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17). Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 18:26 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 8,014 | $0.46 | $3,686.44 |
DisclosureSEC source: 0001613377-17-000002 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,989 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.